Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CellTherEx Consulting AB
AB
Active
Org 5592502578
Beckasinvägen 8, 123 52
Farsta
All other professional, scientific and technical activities n.e.c.
· NACE 7499
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
CellTherEx Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2021
0M
2022
1M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
339
242
1 146
1 929
1 757
Staff expenses
—
−144
−1 031
−1 307
−608
EBITDA
—
0
1
541
1 047
Depreciation & amort.
−0
—
—
—
—
EBIT
0
0
1
541
1 047
Net financials
—
−0
−1
10
45
Profit before tax
0
0
−0
551
1 092
Tax
−0
−0
—
−114
−220
Net profit
0
−0
−0
437
872
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
322
273
1 039
1 604
1 757
Equity
25
24
24
461
1 132
Long-term debt
0
—
—
—
—
Short-term debt
298
249
1 014
1 143
624
Total debt
298
249
1 014
1 143
624
Financial ratios
5-year trend
EBITDA margin
59.6%
This company
15.8%
Market median
+277% vs market
2021
2025
Equity ratio
64.5%
This company
38.2%
Market median
+69% vs market
2021
2025
Return on equity
77.0%
This company
18.4%
Market median
+318% vs market
2021
2025
Net profit margin
49.6%
This company
8.1%
Market median
+512% vs market
2021
2025
Asset turnover
1.00×
This company
1.12×
Market median
+11% vs market
2021
2025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-02-28
View
PDF
More on CellTherEx Consulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
